sulfamethoxypyridazine has been researched along with Multiple Myeloma in 1 studies
Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grupper, C | 1 |
| Girard, J | 1 |
| Elalouf, C | 1 |
| Mikol, F | 1 |
1 other study available for sulfamethoxypyridazine and Multiple Myeloma
| Article | Year |
|---|---|
[Amyloid macroglossia associated with a neuropathy].
Topics: Aged; Amyloidosis; Cardiovascular Diseases; Carpal Tunnel Syndrome; Humans; Laryngeal Diseases; Male | 1969 |